Over the last 60 days, the Zacks Consensus Estimate for the stock moved south for 2017 ... You can see the complete list of today’s Zacks #1 Rank stocks here. BASF SE BASFY currently flaunts a Zacks Rank #1 and has an average …
Chemical maker Methanex Corporation MEOH recorded net profit (attributable to Methanex shareholders) of $24 million or 28 cents per share in the fourth quarter of 2016 as compared with a profit of $10 million or 10 cents per share logged a …
Tennessee-based Chemical maker Eastman Chemical Company (NYSE:EMN) was downgraded to a Zacks Rank #3 (Hold) on May 24. Eastman Chemical recorded earnings of $278 million or $1.89 per share in the first quarter of 2017, higher …
Amarin Corporation (NASDAQ: AMRN) announced today the late December 2012 submission of a Supplemental New …
Dec 7 (Reuters) - BASF AND LETTERONE'S L1 ENERGY::ANNOUNCE THEIR INTENTION TO MERGE THEIR OIL AND GAS SUBSIDIARIES.WINTERSHALL DEA TO BE ONE OF THE LARGEST INDEPENDENT EUROPEAN …
It competes with BASF SE (BASFY), Methanex Corp. (MEOH ... Our recommendation on the stock is supported by a short-term Zacks #3 Rank (Hold). Read the Full Research Report on DD
Oct 10 (Reuters) - RECTICEL NV ::AFFECTED BY NON-CONFORMING TDI SUPPLIES BY BASF‍ .HAS TAKEN IMMEDIATE PRECAUTIONARY MEASURES IN AFFECTED SITES, WITH A TEMPORARY STOP IN PRODUCTION …
All it takes is one FDA approval for a biotech company's stock to soar, but an FDA setback could also cause that same stock to tank. One biotech stock suffered that outcome Monday morning. Sarepta Therapeutics Inc (NASDAQ: SRPT) …
As much as people might wax elegiac for the end of the storied industrial names, the possible mega-deal between Dow Chemical (DOW) and Dupont (DD) makes too much sense for DOW or DD stock holders for it not to happen. That’s …